🔗 Share this article

As the US undertakes sweeping changes to its immunization recommendations, a particular individual has surfaced somewhat surprisingly: Dr. Tracy Beth Høeg, a US-based physician and epidemiologist who rose to prominence by questioning Covid vaccines throughout the pandemic and has concentrated on potential deaths after COVID-19 immunization in her brief time at the Food and Drug Administration.

Scheduled Overhauls to Childhood Immunization Program

Health officials had intended to announce sweeping changes to the childhood immunization program recently, synchronizing the US with the Danish immunization schedule, sources say – a significant shift that would put the US out of step with much of the world with insufficient data for improved outcomes. This reveal has been delayed until the new year.

Rather than Vinay Prasad, Dr. Høeg is set to speak at the event. She was newly appointed acting director of the FDA’s CDER, the fifth person to run the division this calendar year.

A Shift at the Regulatory Body

Høeg's temporary position may indicate a strengthened alliance between the drug and vaccine branches as Dr. Høeg and Prasad strengthen their influence at the agency – and it signals a renewed priority upon dismantling long-standing immunizations at the FDA.

The new acting director has often pushed for discontinuing specific childhood vaccine recommendations in the US in order to be more in line with Denmark's approach, a society with nationalized medicine and a number of inhabitants roughly the population of Wisconsin’s.

In her initial public appearances, she has kept her attention on immunizations – usually the responsibility of Prasad, chief of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to medication approval.

Doubts Over Qualifications

Dr. Høeg has little discernible background in pharmaceutical research, oversight or management, which has been customary for former directors of the CBER. She has been employed at the FDA as a senior adviser to the FDA chief and the vaccine center since March.

“She doesn’t seem to have the necessary background” for overseeing the drug-regulation department, said Jonathan Howard. “She has not conducted a scientific study. She lacks experience in running a sizeable institution. She is not an expert in industry regulation.”

Past heads of the center would “grasp laws and regulations and the underlying principles of drug development”, commented a former acting FDA commissioner. “Frankly, she lacks the sort of resume that prior appointees who ran the center have had.”

This division has an enormous portfolio at the agency, Woodcock stated.

“Many people just focuses on the innovative therapies, but the off-patent medication office approves thousands of generic drugs. There is also a biosimilars program, OTC medication office and more, and each of these need to be supervised,” she explained. “The responsibility you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

There is also, a significant management component to the role, which supervises over 5,000 employees. “It is a massive leadership role, if you perform it correctly,” she said.

Official Statement and Controversial Programs

In response to concerns about Høeg’s qualifications and whether this appointment signifies greater collaboration among FDA leaders on immunizations, a spokesperson stated that the “inquiries stem from flawed assumptions”.

“Her resume matches the duties of her position,” the official stated, pointing to the time Høeg spent guiding the agency head on “pharmaceutical safety and oversight research, including computerized risk analysis and immunization monitoring”.

As acting director, Dr. Høeg inherits the commissioner’s controversial fast-track approval initiative, a disputed one-day therapy clearance system that allegedly concerned her predecessors. “How are these medications being chosen for this expedited pathway? Who makes the choices?” Howard said. “There’s a lot of confidentiality going on at the agency right now.”

Overall, he stated, “the agency appears to be shifting towards less stringent regulations of most medications, except for vaccines.”

Established History on Vaccines

Concerning vaccines, Høeg has a more documented, if concerning, track record, critics said. She released a analysis using unverified crowd-sourced reports to determine the rate of myocarditis following COVID-19 vaccination. She consulted for the Florida top health official Joseph Ladapo, who was said to have changed statistics to imply COVID-19 vaccines are more dangerous than they are.

Included in her “policy goals” for the incoming federal leadership included changing regulations for novel immunizations and halting “optional” immunizations, she remarked after the election on a podcast. At the agency, Dr. Høeg has according to sources proposed barring teenage boys from obtaining Covid vaccinations.

“She’s an all-around true believer who commences with her beliefs and reverse-engineers to accommodate the data in a highly misleading, untruthful way,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Dr. Høeg joined other dissenters, {like|